Jim Corbett has held leadership roles across biotechnology, medical imaging, analytical instruments and in vitro diagnostics.
Could organ-on-a-chip technology help identify drug failures before clinical trials? Jim Corbett of Emulate discusses the ...
Two cancer drugs appeared almost identical in conventional screening, but a new 3D Cell Painting method exposed striking ...
Researchers have found that the TRPV1 pain receptor responds differently to individual stimuli, revealing functional ...
MSA and Parkinson's share the same protein pathology, yet MSA progresses far faster. Could earlier detection reveal why and ...
Two experimental compounds derived from a phase II metabolite have demonstrated improved anti-inflammatory activity in ...
A gene responsible for producing a critical enzyme in inflammatory signalling has been identified after more than 30 years, ...
The right signals can make or break an organoid model. From growth and differentiation to downstream drug testing, cytokines and growth factors are critical to creating cultures researchers can rely ...
A hybrid microrobotic platform combining living bacteria, nanoparticles and targeted chemotherapy has achieved 82.4 percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results